ArticleTranslational oncology2020

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile.

Anne V Yagolovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.